These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8138903)

  • 1. Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy.
    Timmermans J; Moës AJ
    J Pharm Sci; 1994 Jan; 83(1):18-24. PubMed ID: 8138903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroretentive dosage forms.
    Moës AJ
    Crit Rev Ther Drug Carrier Syst; 1993; 10(2):143-95. PubMed ID: 8370085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative evaluation of the gastric transit of floating and non-floating matrix dosage forms].
    Timmermans J
    Bull Mem Acad R Med Belg; 1990; 145(8-9):365-75. PubMed ID: 2099235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the gastrointestinal transit and disintegration behavior of floating and sinking acid-resistant capsules using a novel MRI labeling technique.
    Grimm M; Ball K; Scholz E; Schneider F; Sivert A; Benameur H; Kromrey ML; Kühn JP; Weitschies W
    Eur J Pharm Sci; 2019 Mar; 129():163-172. PubMed ID: 30639530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intragastric behavior and absorption kinetics of a normal and "floating" modified-release capsule of isradipine under fasted and fed conditions.
    Mazer N; Abisch E; Gfeller JC; Laplanche R; Bauerfeind P; Cucala M; Lukachich M; Blum A
    J Pharm Sci; 1988 Aug; 77(8):647-57. PubMed ID: 2974884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Floating dosage forms: an in vivo study demonstrating prolonged gastric retention.
    Whitehead L; Fell JT; Collett JH; Sharma HL; Smith A
    J Control Release; 1998 Oct; 55(1):3-12. PubMed ID: 9795000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro and In Vivo Evaluation of Carbopol 71G NF-Based Mucoadhesive Minitablets as a Gastroretentive Dosage Form.
    Rump A; Tetyczka C; Littringer E; Kromrey ML; Bülow R; Roblegg E; Weitschies W; Grimm M
    Mol Pharm; 2023 Mar; 20(3):1624-1630. PubMed ID: 36705398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention.
    Singh BN; Kim KH
    J Control Release; 2000 Feb; 63(3):235-59. PubMed ID: 10601721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bilayer floating capsule: a stomach-directed drug delivery system for misoprostol.
    Oth M; Franz M; Timmermans J; Möes A
    Pharm Res; 1992 Mar; 9(3):298-302. PubMed ID: 1614959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Floating microspheres: to prolong the gastric retention time in stomach.
    Bhadouriya P; Kumar M; Pathak K
    Curr Drug Deliv; 2012 May; 9(3):315-24. PubMed ID: 22023206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of gastric residence time of the Heidelberg capsule in humans: effect of varying food composition.
    Mojaverian P; Ferguson RK; Vlasses PH; Rocci ML; Oren A; Fix JA; Caldwell LJ; Gardner C
    Gastroenterology; 1985 Aug; 89(2):392-7. PubMed ID: 3891497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans.
    Sato Y; Kawashima Y; Takeuchi H; Yamamoto H
    Int J Pharm; 2004 May; 275(1-2):97-107. PubMed ID: 15081141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro and In Vivo Evaluation of Magnetic Floating Dosage Form by Alternating Current Biosusceptometry.
    Rodrigues GS; Barboza JM; Buranello LP; Brandão VM; Ferrari PC; Soares GA; Miranda JRA
    Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gender, posture, and age on gastric residence time of an indigestible solid: pharmaceutical considerations.
    Mojaverian P; Vlasses PH; Kellner PE; Rocci ML
    Pharm Res; 1988 Oct; 5(10):639-44. PubMed ID: 3244616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of dual-mode floating gastroretentive tablets containing itraconazole.
    Kim JY; Rhee YS; Park CW; Ha JM; Park ES
    Drug Deliv; 2014 Nov; 21(7):519-29. PubMed ID: 24245857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and statistical optimization of gastric floating alginate/oil/chitosan capsules loading procyanidins: in vitro and in vivo evaluations.
    Chen R; Guo X; Liu X; Cui H; Wang R; Han J
    Int J Biol Macromol; 2018 Mar; 108():1082-1091. PubMed ID: 29128589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transit of pharmaceutical dosage forms through the small intestine.
    Davis SS; Hardy JG; Fara JW
    Gut; 1986 Aug; 27(8):886-92. PubMed ID: 3732895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastroretentive drug delivery systems.
    Streubel A; Siepmann J; Bodmeier R
    Expert Opin Drug Deliv; 2006 Mar; 3(2):217-33. PubMed ID: 16506949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastro intestinal tracking and gastric emptying of solid dosage forms in rats using X-ray imaging.
    Saphier S; Rosner A; Brandeis R; Karton Y
    Int J Pharm; 2010 Mar; 388(1-2):190-5. PubMed ID: 20079410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric pH and gastric residence time in fasted and fed conscious cynomolgus monkeys using the Bravo pH system.
    Chen EP; Mahar Doan KM; Portelli S; Coatney R; Vaden V; Shi W
    Pharm Res; 2008 Jan; 25(1):123-34. PubMed ID: 17612796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.